1 |
Solomon DH, Kavanaugh AJ, Schur PH. Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing[J]. Arthritis Rheum, 2002, 47(4):434-444.
|
2 |
Aringer M, Costenbader K, Daikh D, et al. 2019 European league against rheumatism/American college of rheumatology classification criteria for systemic lupus erythematosus[J]. Arthritis Rheumatol, 2019, 71(9):1400-1412.
|
3 |
Mummert E, Fritzler MJ, Sjöwall C, et al. The clinical utility of anti-double-stranded DNA antibodies and the challenges of their determination[J]. J Immunol Methods, 2018, 459:11-19.
|
4 |
Frodlund M, Wetterö J, Dahle C, et al. Longitudinal anti-nuclear antibody (ANA) seroconversion in systemic lupus erythematosus: a prospective study of Swedish cases with recent-onset disease[J]. Clin Exp Immunol, 2020, 199(3):245-254.
|
5 |
Invernizzi P, Floreani A, Carbone M, et al. Primary biliary cholangitis: advances in management and treatment of the disease[J]. Dig Liver Dis, 2017, 49(8):841-846.
|
6 |
Leuschner U. Primary biliary cirrhosis-presentation and diagnosis[J]. Clin Liver Dis, 2003, 7:741-758.
|
7 |
van den Hoogen F, Khanna D, Fransen J, et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative[J]. Arthritis Rheum, 2013, 65(11):2737-2747.
|
8 |
Mahler M, Meroni P L, Bossuyt X, et al. Current concepts and future directions for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies[J]. J Immunol Res, 2014, 2014:315179.
|
9 |
Wei Q, Jiang Y, Xiao M, et al. Comparison of chemiluminescence microparticle immunoassay, indirect immunofluorescence assay, linear immunoassay and multiple microbead immunoassay detecting autoantibodies in systemic lupus erythematosus[J]. Scand J Immunol, 2019, 91(3):e12849.
|
10 |
Chan EK, Damoiseaux J, Carballo OG, et al. Report of the first international consensus on standardized nomenclature of antinuclear antibody HEp-2 cell patterns 2014-2015[J]. Front Immunol, 2015, 6:412.
|
11 |
Sack U, Conrad K, Csernok E, et al. Autoantibody detection using indirect immunofluorescence on HEp-2 cells[J]. Ann N Y Acad Sci, 2009, 1173:166-173.
|
12 |
车文英, 谭延国, 韦希明. 312例抗核抗体与抗细胞核细胞浆抗体谱检测结果的分析[J]. 中国实验诊断学, 2008, 12(8):1031-1033.
|
13 |
Franceschini F, Cavazzana I. Anti-Ro/SSA and La/SSB antibodies[J]. Autoimmunity, 2005, 38(1):55-63.
|
14 |
Sowa M, Hiemann R, Schierack P, et al. Next-generation autoantibody testing by combination of screening and confirmation-the CytoBead® technology[J]. Clin Rev Allergy Immunol, 2017, 53(1):87-104.
|
15 |
Sherer Y, Gorstein A, Fritzler MJ, et al. Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients[J]. Semin Arthritis Rheum, 2004, 34(2):501-537.
|
16 |
Schulte-Pelkum J, Fritzler M, Mahler M. Latest update on the Ro/SS-A autoantibody system[J]. Autoimmun Rev, 2009, 8:632-637.
|
17 |
Su Y, Jia RL, Han L, et al. Role of anti-nucleosome antibody in the diagnosis of systemic lupus erythematosus[J]. Clin Immunol, 2007, 122:115-120.
|
18 |
Isshi K, Hirohata S. Differential roles of the anti-ribosomal P antineuronal antibody in the pathogenesis of central nerveous system involvement in systemic lupus erythematosus[J]. Arthritis Rheum, 1998, 41:1819.
|